All Relations between decision making and itp

Publication Sentence Publish Date Extraction Date Species
Hillary Maitland, Catherine Lambert, Waleed Ghanim. Patient-centric care in primary immune thrombocytopenia (ITP): shared decision-making and assessment of health-related quality of life. Hematology (Amsterdam, Netherlands). vol 29. issue 1. 2024-07-08. PMID:38975804. patient-centric care in primary immune thrombocytopenia (itp): shared decision-making and assessment of health-related quality of life. 2024-07-08 2024-07-11 Not clear
Tomás José González-López, Abelardo Bárez, Ángel Bernardo-Gutiérrez, Silvia Bernat, Fernando Fernández-Fuertes, José María Guinea de Castro, Reyes Jiménez-Bárcenas, Isidro Jarqu. Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus. Platelets. vol 35. issue 1. 2024-05-14. PMID:38742687. in the present study, the delphi methodology has been used to get a consensus on the management of adult patients with itp in spain and to help in decision-making. 2024-05-14 2024-05-27 Not clear
Char M Witmer, Michele P Lamber. Sports participation in chronic immune thrombocytopenia: Safer than you thought? Pediatric blood & cancer. 2023-09-21. PMID:37731177. pediatric patients with chronic immune thrombocytopenia (itp) commonly have activity limitations placed to prevent injury without data guiding clinical decision-making. 2023-09-21 2023-10-07 Not clear
Zhuo-Yu An, Ye-Jun Wu, Yu Hou, Heng Mei, Wei-Xia Nong, Wen-Qian Li, Hu Zhou, Ru Feng, Jian-Ping Shen, Jun Peng, Hai Zhou, Yi Liu, Yong-Ping Song, Lin-Hua Yang, Mei-Yun Fang, Jian-Yong Li, Yun-Feng Cheng, Peng Liu, Ya-Jing Xu, Zhao Wang, Yi Luo, Zhen Cai, Hui Liu, Jing-Wen Wang, Juan Li, Xi Zhang, Zi-Min Sun, Xiao-Yu Zhu, Xin Wang, Rong Fu, Liang Huang, Shao-Yuan Wang, Tong-Hua Yang, Li-Ping Su, Liang-Ming Ma, Xie-Qun Chen, Dai-Hong Liu, Hong-Xia Yao, Jia Feng, Hong-Yu Zhang, Ming Jiang, Ze-Ping Zhou, Wen-Sheng Wang, Xu-Liang Shen, Yangjin Baima, Yue-Ying Li, Qian-Fei Wang, Qiu-Sha Huang, Hai-Xia Fu, Xiao-Lu Zhu, Yun He, Qian Jiang, Hao Jiang, Jin Lu, Xiang-Yu Zhao, Ying-Jun Chang, Tao Wu, Yao-Zhu Pan, Lin Qiu, Da Gao, A-Rong Jin, Wei Li, Su-Jun Gao, Lei Zhang, Ming Hou, Xiao-Jun Huang, Xiao-Hui Zhan. A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study. Science bulletin. 2023-08-20. PMID:37599175. this convenient web-based tool based on a novel algorithm can rapidly identify the bleeding risk profile of patients with itp and facilitate clinical decision-making and reduce the occurrence of adversities. 2023-08-20 2023-09-07 Not clear
Dražen Pulanić, Angelika Bátorová, Imre Bodó, Libor Červinek, Ioana Ionita, Toshko Lissitchkov, Anahit Melikyan, Maria Podolak-Dawidzia. Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus. Annals of hematology. 2023-02-24. PMID:36826482. this work will facilitate informed decision-making for healthcare providers treating adult itp patients with tpo-ras. 2023-02-24 2023-08-14 Not clear
Shin Yeu Ong, Chuen Wen Tan, Vajjhala Ramya, Aisyah A Malik, Xiu Hue Lee, Jordan C C Hwang, Yong Yang, Heng Joo Ng, Lai Heng Le. Risk factors and predictors of treatment responses and complications in immune thrombocytopenia. Annals of hematology. vol 100. issue 3. 2021-03-05. PMID:33515047. lack of data on the platelet count threshold associated with bleeding and infection risk associated with itp treatment limits risk/benefit clinical decision making. 2021-03-05 2023-08-13 Not clear
Rachael F Grace, Jenny M Despotovic, Carolyn M Bennett, James B Bussel, Michelle Neier, Cindy Neunert, Shelley E Crary, Yves D Pastore, Robert J Klaassen, Jennifer A Rothman, Kerry Hege, Vicky R Breakey, Melissa J Rose, Kristin A Shimano, George R Buchanan, Amy Geddis, Kristina M Haley, Adonis Lorenzana, Alexis Thompson, Michael Jeng, Ellis J Neufeld, Travis Brown, Peter W Forbes, Michele P Lamber. Physician decision making in selection of second-line treatments in immune thrombocytopenia in children. American journal of hematology. vol 93. issue 7. 2019-07-10. PMID:29659042. this study illustrates the complexity and many factors involved in decision-making in selecting second-line itp treatments, given the absence of comparative trials. 2019-07-10 2023-08-13 Not clear
Xin-Guang Liu, Xiao-Chuan Bai, Fang-Ping Chen, Yun-Feng Cheng, Ke-Sheng Dai, Mei-Yun Fang, Jian-Ming Feng, Yu-Ping Gong, Tao Guo, Xin-Hong Guo, Yue Han, Luo-Jia Hong, Yu Hu, Bao-Lai Hua, Rui-Bing Huang, Yan Li, Jun Peng, Mi-Mi Shu, Jing Sun, Pei-Yan Sun, Yu-Qian Sun, Chun-Sen Wang, Shu-Jie Wang, Xiao-Min Wang, Cong-Ming Wu, Wen-Man Wu, Zhen-Yu Yan, Feng-E Yang, Lin-Hua Yang, Ren-Chi Yang, Tong-Hua Yang, Xu Ye, Guang-Sen Zhang, Lei Zhang, Chang-Cheng Zheng, Hu Zhou, Min Zhou, Rong-Fu Zhou, Ze-Ping Zhou, Hong-Li Zhu, Tie-Nan Zhu, Ming Ho. Chinese guidelines for treatment of adult primary immune thrombocytopenia. International journal of hematology. vol 107. issue 6. 2018-06-27. PMID:29619624. based on current consensus positions and new emerging clinical evidence, the thrombosis and hemostasis group of the chinese society of hematology issued chinese guidelines for management of adult itp, which aim to provide evidence-based recommendations for clinical decision making. 2018-06-27 2023-08-13 Not clear
Carolyn E Beck, Katherine M Boydell, Elaine Stasiulis, Victor S Blanchette, Hilary Llewellyn-Thomas, Catherine S Birken, Vicky R Breakey, Patricia C Parki. Shared decision making in the management of children with newly diagnosed immune thrombocytopenia. Journal of pediatric hematology/oncology. vol 36. issue 7. 2014-11-18. PMID:24577546. using focus groups, we studied children with itp, parents of children with itp, and health care professionals, inquiring about participants' experience with decision support and decision making in newly diagnosed itp. 2014-11-18 2023-08-12 human
Carolyn E Beck, Katherine M Boydell, Elaine Stasiulis, Victor S Blanchette, Hilary Llewellyn-Thomas, Catherine S Birken, Vicky R Breakey, Patricia C Parki. Shared decision making in the management of children with newly diagnosed immune thrombocytopenia. Journal of pediatric hematology/oncology. vol 36. issue 7. 2014-11-18. PMID:24577546. this study aimed to examine the treatment decision-making process for children hospitalized with newly diagnosed immune thrombocytopenia (itp). 2014-11-18 2023-08-12 human
Gilberto Vizcaíno, Jennifer Vizcaíno-Carruy. [The number needed to treat as a measure of effect in the treatment of primary immune thrombocytopenia]. Investigacion clinica. vol 53. issue 1. 2013-05-16. PMID:22524105. in conclusion, given the advantages of the arr and the nnt for clinical decision making, it can be suggested that these measurements of effect should also be reported, in addition to other statistical measurements for itp treatment or any observational study with dichotomous or binary outcomes. 2013-05-16 2023-08-12 Not clear
Adam Cuker, Douglas B Cine. Immune thrombocytopenia. Hematology. American Society of Hematology. Education Program. vol 2010. 2011-04-22. PMID:21239822. recent studies suggest the potential for aggressive therapy at the time of diagnosis to alter the natural history of itp and point to the importance of quality-of-life considerations in therapeutic decision making. 2011-04-22 2023-08-12 Not clear
Javier Palau, Isidro Jarque, Miguel A San. Long-term management of chronic immune thrombocytopenic purpura in adults. International journal of general medicine. vol 3. 2010-11-15. PMID:21042569. additional factors, such as age, lifestyle, and uremia can also influence the hemorrhagic risk and should be carefully assessed before decision-making on the appropriate management of patients with less severe forms of itp. 2010-11-15 2023-08-12 Not clear
M Chen, L-L Zhang, M Hu, J Gao, R-S Ton. Cost-effectiveness of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP)--a systematic review. The Journal of international medical research. vol 36. issue 3. 2008-07-22. PMID:18534141. the cost-effectiveness of treatment for acute paediatric idiopathic thrombocytopenic purpura (itp) was assessed to provide evidence for health-care decision making and rational drug use. 2008-07-22 2023-08-12 Not clear